FDA NDC Directory · JSON-LD · Markdown

RELAFEN DS

NDC 15370-170 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameNABUMETONE
Labeler / ManufacturerCarwin Pharmaceutical Associates, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA203166
Dosage form / routeTABLET · ORAL
Active ingredientsNABUMETONE (1000 mg/1)
Marketing started20190920
Package count4

External sources

Source: openFDA. Public-domain (CC0).